Ennis, Inc. (NYSE:EBF – Get Free Report) declared a quarterly dividend on Tuesday, September 24th, Wall Street Journal reports. Stockholders of record on Friday, October 11th will be given a dividend of 0.25 per share by the industrial products company on Friday, November 8th. This represents a $1.00 annualized dividend and a dividend yield of 3.95%. The ex-dividend date is Friday, October 11th.
Ennis has raised its dividend payment by an average of 3.6% per year over the last three years.
Ennis Trading Up 2.8 %
Shares of Ennis stock traded up $0.70 during trading on Tuesday, hitting $25.34. 188,682 shares of the stock were exchanged, compared to its average volume of 107,650. The stock has a market capitalization of $658.43 million, a price-to-earnings ratio of 15.47 and a beta of 0.40. The company has a fifty day moving average price of $23.26 and a 200-day moving average price of $21.57. Ennis has a 1-year low of $18.88 and a 1-year high of $25.75.
Analyst Ratings Changes
Read Our Latest Research Report on EBF
About Ennis
Ennis, Inc manufactures and sells business forms and other business products in the United States. The company offers snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure sensitive products under the Ennis, Royal Business Forms, Block Graphics, 360º Custom Labels, ColorWorx, Enfusion, Uncompromised Check Solutions, VersaSeal, Ad Concepts, FormSource Limited, Star Award Ribbon Company, Witt Printing, B&D Litho, Genforms, PrintGraphics, Calibrated Forms, PrintXcel, Printegra, Forms Manufacturers, Mutual Graphics, TRI-C Business Forms, Major Business Systems, Independent Printing, Hoosier Data Forms, Hayes Graphics, Wright Business Graphics, Wright 360, Integrated Print & Graphics, the Flesh Company, Impressions Direct, and AmeriPrint brands.
Read More
- Five stocks we like better than Ennis
- What Are the FAANG Stocks and Are They Good Investments?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Business Services Stocks Investing
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Buy P&G Now, Before It Sets A New All-Time High
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Ennis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ennis and related companies with MarketBeat.com's FREE daily email newsletter.